COVID-19 Updates

The company said its independently developed mRNA vaccine SYS6006 targets some major Omicron variants and its booster dose showed…

‘Ab-CoV’ can be a vital resource for researchers to develop therapeutic strategies against new variants of coronaviruses by…

The XBB.1.5 S protein was also found to be highly resistant to neutralisation antibodies elicited by breakthrough infection with…

There are currently 16 COVID-19 drugs in clinical development in China, five of which are in Phase III. Most of these drugs in the…

The protein-based vaccine was expected to convince those sceptical of the new mRNA-based vaccines against the virus from rivals…

The research, published in the Canadian Medical Association Journal, aimed to evaluate the effectiveness of paxlovid, a…

The study is currently the only one in the world that monitored the population for more than a year, taking into account numerous…

iNNCOVACC is the world’s first intra-nasal COVID-19 vaccine to receive approval for the primary two-dose schedule, and as a…

The unit, based in the commercial hub of Shanghai, has built a research and development platform, as well as workshops with annual…

Speaking during the World Economic Forum (WEF) Annual Meeting 2023, Poonawalla said he is optimistic about the cooperation